Mainland China

Type 2 diabetes in Mainland China: Shifting treatment patterns

Mainland China has gone through a series of regulatory and reimbursement reforms in recent years in an effort to keep pace with its dynamic economic and demographic landscape. Clarivate market assessment expert Karan Verma discusses the role of these reforms in Mainland China’s type 2 diabetes market and how they could broaden access to innovative […]

Volume-Based Procurement in Mainland China: Key trends and planning future strategies

Mainland China has gone through a series of regulatory and reimbursement reforms in recent years in an effort to keep pace with its dynamic economic and demographic landscape. Clarivate expert Karan Verma discusses how the Volume-Based Procurement program is transforming the generics landscape, increasing patient access and prompting manufactures to rethink strategies.   Remodeling Mainland […]

Mainland China’s anticipated biosimilar boom – potential and key drivers of the market

The market of major biologics in Mainland China has tripled since 2017, with the potential to grow five-fold over the next ten years – which could drive biosimilars growth. Clarivate expert Akash Saini discusses this market’s potential and key drivers.    The approval of Shanghai Henlius Biotech’s HLX01—a biosimilar of rituximab (Roche’s MabThera)—in February 2019 […]

McKinsey report and Clarivate data identify global innovation’s pivot to Asia

IP activity in Asia has undergone two unmistakeable shifts in recent years, both spearheaded by Mainland China. The first has progressed over the long-term and seen Asia become a global innovation hub and take the lead in global patent filings. The second shift, which has taken place much more rapidly, concerns a pivot away from […]

McKinsey report and Clarivate data identify global innovation’s pivot to Asia

IP activity in Asia has undergone two unmistakeable shifts in recent years, both spearheaded by Mainland China. The first has progressed over the long-term and seen Asia become a global innovation hub and take the lead in global patent filings. The second shift, which has taken place much more rapidly, concerns a pivot away from […]